Drugs interactions for Bimzelx®
- 261 Major drug interactions (including ingredients like Abatacept, Abemaciclib, Acalabrutinib)
- 451 Moderate drug interactions (including ingredients like Abrocitinib, Acebutolol, Acetaminophen)
- 106 Minor drug interactions (including ingredients like Aducanumab, Alirocumab, Allogeneic processed thymus tissue)
818 interactions for Bimzelx®The risk or severity of adverse effects can be increased when Abatacept is combined with Bimekizumab.The metabolism of Abemaciclib can be increased when combined with Bimekizumab.The metabolism of Acalabrutinib can be increased when combined with Bimekizumab.The metabolism of Acenocoumarol can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimekizumab.The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bimekizumab.The metabolism of Alectinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Bimekizumab.The metabolism of Alpelisib can be increased when combined with Bimekizumab.The metabolism of Aminophylline can be increased when combined with Bimekizumab.The metabolism of Amiodarone can be increased when combined with Bimekizumab.The metabolism of Amitriptyline can be increased when combined with Bimekizumab.The metabolism of Amoxapine can be increased when combined with Bimekizumab.The metabolism of Anagrelide can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Anakinra is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Anifrolumab is combined with Bimekizumab.The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Avacopan.The metabolism of Axitinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Azacitidine is combined with Bimekizumab.The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Baricitinib is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Basiliximab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Belatacept is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Belimumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Belinostat is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Belumosudil.The metabolism of Bendamustine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Betamethasone is combined with Bimekizumab.The metabolism of Bicalutamide can be increased when combined with Bimekizumab.The metabolism of Binimetinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bleomycin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Blinatumomab is combined with Bimekizumab.The metabolism of Bortezomib can be increased when combined with Bimekizumab.The metabolism of Bosutinib can be increased when combined with Bimekizumab.The metabolism of Brentuximab vedotin can be increased when combined with Bimekizumab.The metabolism of Brigatinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Brodalumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Budesonide is combined with Bimekizumab.The metabolism of Busulfan can be increased when combined with Bimekizumab.The metabolism of Cabazitaxel can be increased when combined with Bimekizumab.The metabolism of Cabergoline can be increased when combined with Bimekizumab.The metabolism of Cabozantinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Canakinumab is combined with Bimekizumab.The metabolism of Capecitabine can be increased when combined with Bimekizumab.The metabolism of Carbamazepine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Carboplatin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Carfilzomib is combined with Bimekizumab.The metabolism of Ceritinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Bimekizumab.The therapeutic efficacy of Chikungunya vaccine (live, attenuated) can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Chlorambucil is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Cisplatin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Clofarabine is combined with Bimekizumab.The metabolism of Clomipramine can be increased when combined with Bimekizumab.The metabolism of Clonidine can be increased when combined with Bimekizumab.The metabolism of Cobimetinib can be increased when combined with Bimekizumab.The metabolism of Conivaptan can be increased when combined with Bimekizumab.The metabolism of Copanlisib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Corticotropin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Bimekizumab.The metabolism of Crizotinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Crovalimab.The metabolism of Cyclophosphamide can be increased when combined with Bimekizumab.Bimekizumab may increase the immunosuppressive activities of Cyclosporine.The risk or severity of adverse effects can be increased when Cytarabine is combined with Bimekizumab.The metabolism of Dabrafenib can be increased when combined with Bimekizumab.The metabolism of Dacarbazine can be increased when combined with Bimekizumab.The metabolism of Dacomitinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Dactinomycin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Danicopan.The metabolism of Dasatinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Daunorubicin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Decitabine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Deflazacort is combined with Bimekizumab.The metabolism of Desipramine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Desoximetasone is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Deucravacitinib.The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Bimekizumab.The metabolism of Dihydroergotamine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Dinutuximab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Diroximel fumarate.The metabolism of Docetaxel can be increased when combined with Bimekizumab.The metabolism of Dofetilide can be increased when combined with Bimekizumab.The metabolism of Doxorubicin can be increased when combined with Bimekizumab.The metabolism of Dronedarone can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Eculizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Efgartigimod alfa.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Emapalumab.The metabolism of Enasidenib can be increased when combined with Bimekizumab.The metabolism of Entrectinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Epirubicin is combined with Bimekizumab.The metabolism of Erdafitinib can be increased when combined with Bimekizumab.The metabolism of Ergotamine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Eribulin is combined with Bimekizumab.The metabolism of Erlotinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Etanercept is combined with Bimekizumab.The metabolism of Etoposide can be increased when combined with Bimekizumab.The metabolism of Everolimus can be increased when combined with Bimekizumab.The metabolism of Flecainide can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Floxuridine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Flucytosine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Fludarabine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Flunisolide is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Fluocinonide is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Fluorometholone is combined with Bimekizumab.The metabolism of Fluorouracil can be increased when combined with Bimekizumab.The metabolism of Fosphenytoin can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Glatiramer is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Golimumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Guselkumab is combined with Bimekizumab.The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Hydrocortisone succinate.The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Bimekizumab.The metabolism of Idelalisib can be increased when combined with Bimekizumab.The metabolism of Ifosfamide can be increased when combined with Bimekizumab.The metabolism of Imipramine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Infliximab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bimekizumab.The metabolism of Irinotecan can be increased when combined with Bimekizumab.The metabolism of Ivosidenib can be increased when combined with Bimekizumab.The metabolism of Ixabepilone can be increased when combined with Bimekizumab.The metabolism of Ixazomib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ixekizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Lenalidomide is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Linezolid is combined with Bimekizumab.The metabolism of Lomitapide can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Lomustine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Melphalan is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Mepolizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Methimazole is combined with Bimekizumab.The metabolism of Methotrexate can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Bimekizumab.The metabolism of Midostaurin can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Mirikizumab.The risk or severity of adverse effects can be increased when Mitomycin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Mometasone furoate.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Monomethyl fumarate.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Mosunetuzumab.The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Bimekizumab.The risk or severity of immunosuppression can be increased when Bimekizumab is combined with Natalizumab.The risk or severity of adverse effects can be increased when Nelarabine is combined with Bimekizumab.The metabolism of Neratinib can be increased when combined with Bimekizumab.The metabolism of Nilotinib can be increased when combined with Bimekizumab.The metabolism of Nortriptyline can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ofatumumab is combined with Bimekizumab.The metabolism of Olaparib can be increased when combined with Bimekizumab.The metabolism of Osimertinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ozanimod is combined with Bimekizumab.The metabolism of Paclitaxel can be increased when combined with Bimekizumab.The metabolism of Palbociclib can be increased when combined with Bimekizumab.The metabolism of Panobinostat can be increased when combined with Bimekizumab.The metabolism of Pazopanib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Pegaspargase is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Pegcetacoplan.The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Penicillamine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Pentostatin is combined with Bimekizumab.The metabolism of Pexidartinib can be increased when combined with Bimekizumab.The metabolism of Phenobarbital can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Phenylalanine is combined with Bimekizumab.The metabolism of Phenytoin can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bimekizumab.The metabolism of Pimozide can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Pirtobrutinib.The metabolism of Pomalidomide can be increased when combined with Bimekizumab.The metabolism of Ponatinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Pralatrexate is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Prednisolone is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Prednisone is combined with Bimekizumab.The metabolism of Procainamide can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Procarbazine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Bimekizumab.The metabolism of Quinidine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ravulizumab is combined with Bimekizumab.The metabolism of Regorafenib can be increased when combined with Bimekizumab.The metabolism of Ribociclib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Rilonacept is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Risankizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Ritlecitinib.The risk or severity of adverse effects can be increased when Rituximab is combined with Bimekizumab.The metabolism of Romidepsin can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Ropeginterferon alfa-2b.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Rozanolixizumab.The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Bimekizumab.The metabolism of Ruxolitinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Sarilumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Satralizumab.The risk or severity of adverse effects can be increased when Secukinumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Siltuximab is combined with Bimekizumab.The metabolism of Siponimod can be increased when combined with Bimekizumab.The metabolism of Sirolimus can be increased when combined with Bimekizumab.The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Bimekizumab.The metabolism of Sonidegib can be increased when combined with Bimekizumab.The metabolism of Sorafenib can be increased when combined with Bimekizumab.The metabolism of Sotalol can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Spesolimab.The risk or severity of adverse effects can be increased when Streptozocin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Bimekizumab.The metabolism of Sunitinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Sutimlimab.The metabolism of Tamoxifen can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Temozolomide is combined with Bimekizumab.The metabolism of Temsirolimus can be increased when combined with Bimekizumab.The metabolism of Teniposide can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Teprotumumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Teriflunomide is combined with Bimekizumab.The metabolism of Theophylline can be increased when combined with Bimekizumab.The metabolism of Thiotepa can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Tioguanine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Tixocortol is combined with Bimekizumab.The metabolism of Tizanidine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bimekizumab.The metabolism of Tolvaptan can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Topotecan is combined with Bimekizumab.The metabolism of Trabectedin can be increased when combined with Bimekizumab.The metabolism of Trastuzumab emtansine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Trifluridine is combined with Bimekizumab.The metabolism of Trimipramine can be increased when combined with Bimekizumab.The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Upadacitinib.The metabolism of Vandetanib can be increased when combined with Bimekizumab.The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Vedolizumab is combined with Bimekizumab.The metabolism of Vemurafenib can be increased when combined with Bimekizumab.The metabolism of Venetoclax can be increased when combined with Bimekizumab.The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Vilanterol is combined with Bimekizumab.The metabolism of Vinblastine can be increased when combined with Bimekizumab.The metabolism of Vincristine can be increased when combined with Bimekizumab.The metabolism of Vinorelbine can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Voclosporin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Vorinostat is combined with Bimekizumab.The metabolism of Warfarin can be increased when combined with Bimekizumab.The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Bimekizumab.The metabolism of Zanubrutinib can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Zilucoplan.The metabolism of Abrocitinib can be increased when combined with Bimekizumab.The metabolism of Acebutolol can be increased when combined with Bimekizumab.The metabolism of Acetaminophen can be increased when combined with Bimekizumab.The metabolism of Acetylsalicylic acid can be increased when combined with Bimekizumab.The metabolism of Acyclovir can be increased when combined with Bimekizumab.The metabolism of Albendazole can be increased when combined with Bimekizumab.The metabolism of Alfentanil can be increased when combined with Bimekizumab.The metabolism of Almotriptan can be increased when combined with Bimekizumab.The metabolism of Alogliptin can be increased when combined with Bimekizumab.The metabolism of Alosetron can be increased when combined with Bimekizumab.The metabolism of Alprazolam can be increased when combined with Bimekizumab.The metabolism of Ambrisentan can be increased when combined with Bimekizumab.The metabolism of Amphetamine can be increased when combined with Bimekizumab.The metabolism of Anastrozole can be increased when combined with Bimekizumab.The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Bimekizumab.The metabolism of Antipyrine can be increased when combined with Bimekizumab.The metabolism of Apalutamide can be increased when combined with Bimekizumab.The metabolism of Apixaban can be increased when combined with Bimekizumab.The metabolism of Apomorphine can be increased when combined with Bimekizumab.The metabolism of Apremilast can be increased when combined with Bimekizumab.The metabolism of Aprepitant can be increased when combined with Bimekizumab.The metabolism of Arformoterol can be increased when combined with Bimekizumab.The metabolism of Aripiprazole can be increased when combined with Bimekizumab.The metabolism of Aripiprazole lauroxil can be increased when combined with Bimekizumab.The metabolism of Artemether can be increased when combined with Bimekizumab.The metabolism of Asenapine can be increased when combined with Bimekizumab.The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Bimekizumab.The metabolism of Asunaprevir can be increased when combined with Bimekizumab.The metabolism of Atazanavir can be increased when combined with Bimekizumab.The metabolism of Atenolol can be increased when combined with Bimekizumab.The metabolism of Atomoxetine can be increased when combined with Bimekizumab.The metabolism of Atorvastatin can be increased when combined with Bimekizumab.The metabolism of Avanafil can be increased when combined with Bimekizumab.The metabolism of Avapritinib can be increased when combined with Bimekizumab.The metabolism of Avatrombopag can be increased when combined with Bimekizumab.The metabolism of Azathioprine can be increased when combined with Bimekizumab.The metabolism of Azelastine can be increased when combined with Bimekizumab.The metabolism of Azithromycin can be increased when combined with Bimekizumab.The metabolism of Belzutifan can be increased when combined with Bimekizumab.The metabolism of Benzatropine can be increased when combined with Bimekizumab.The metabolism of Benzocaine can be increased when combined with Bimekizumab.The metabolism of Benzphetamine can be increased when combined with Bimekizumab.The metabolism of Benzyl alcohol can be increased when combined with Bimekizumab.The metabolism of Betaxolol can be increased when combined with Bimekizumab.The metabolism of Bexarotene can be increased when combined with Bimekizumab.The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Bimekizumab.The metabolism of Bosentan can be increased when combined with Bimekizumab.The metabolism of Brexpiprazole can be increased when combined with Bimekizumab.The metabolism of Brivaracetam can be increased when combined with Bimekizumab.The metabolism of Bromotheophylline can be increased when combined with Bimekizumab.The metabolism of Brompheniramine can be increased when combined with Bimekizumab.The metabolism of Bupivacaine can be increased when combined with Bimekizumab.The metabolism of Buprenorphine can be increased when combined with Bimekizumab.The metabolism of Bupropion can be increased when combined with Bimekizumab.The metabolism of Buspirone can be increased when combined with Bimekizumab.The metabolism of Caffeine can be increased when combined with Bimekizumab.The metabolism of Candesartan cilexetil can be increased when combined with Bimekizumab.The metabolism of Cannabidiol can be increased when combined with Bimekizumab.The metabolism of Capsaicin can be increased when combined with Bimekizumab.The metabolism of Carisoprodol can be increased when combined with Bimekizumab.The metabolism of Carmustine can be increased when combined with Bimekizumab.The metabolism of Carvedilol can be increased when combined with Bimekizumab.The metabolism of Celecoxib can be increased when combined with Bimekizumab.The metabolism of Cenobamate can be increased when combined with Bimekizumab.The metabolism of Cephalexin can be increased when combined with Bimekizumab.The metabolism of Cevimeline can be increased when combined with Bimekizumab.The metabolism of Chloroquine can be increased when combined with Bimekizumab.The metabolism of Chlorpheniramine can be increased when combined with Bimekizumab.The metabolism of Chlorpromazine can be increased when combined with Bimekizumab.The metabolism of Chlorzoxazone can be increased when combined with Bimekizumab.The metabolism of Ciclesonide can be increased when combined with Bimekizumab.The metabolism of Cilostazol can be increased when combined with Bimekizumab.The metabolism of Cinacalcet can be increased when combined with Bimekizumab.The metabolism of Citalopram can be increased when combined with Bimekizumab.The metabolism of Clarithromycin can be increased when combined with Bimekizumab.The metabolism of Clevidipine can be increased when combined with Bimekizumab.The metabolism of Clindamycin can be increased when combined with Bimekizumab.The metabolism of Clobazam can be increased when combined with Bimekizumab.The metabolism of Clopidogrel can be increased when combined with Bimekizumab.The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Bimekizumab.The metabolism of Clozapine can be increased when combined with Bimekizumab.The metabolism of Cobicistat can be increased when combined with Bimekizumab.The metabolism of Codeine can be increased when combined with Bimekizumab.The metabolism of Conjugated estrogens can be increased when combined with Bimekizumab.The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Bimekizumab.The metabolism of Cyclobenzaprine can be increased when combined with Bimekizumab.The metabolism of Daprodustat can be increased when combined with Bimekizumab.The metabolism of Dapsone can be increased when combined with Bimekizumab.The metabolism of Darifenacin can be increased when combined with Bimekizumab.The metabolism of Dasabuvir can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Denosumab is combined with Bimekizumab.The metabolism of Desogestrel can be increased when combined with Bimekizumab.The metabolism of Desvenlafaxine can be increased when combined with Bimekizumab.The metabolism of Deuruxolitinib can be increased when combined with Bimekizumab.The metabolism of Deutetrabenazine can be increased when combined with Bimekizumab.The metabolism of Dexamethasone can be increased when combined with Bimekizumab.The metabolism of Dexamethasone acetate can be increased when combined with Bimekizumab.The metabolism of Dexchlorpheniramine maleate can be increased when combined with Bimekizumab.The metabolism of Dexlansoprazole can be increased when combined with Bimekizumab.The metabolism of Dextroamphetamine can be increased when combined with Bimekizumab.The metabolism of Dextromethorphan can be increased when combined with Bimekizumab.The metabolism of Dextropropoxyphene can be increased when combined with Bimekizumab.The metabolism of Diazepam can be increased when combined with Bimekizumab.The metabolism of Diazoxide can be increased when combined with Bimekizumab.The metabolism of Diclofenac can be increased when combined with Bimekizumab.The metabolism of Dihydrocodeine can be increased when combined with Bimekizumab.The metabolism of Dihydroergocornine can be increased when combined with Bimekizumab.The metabolism of Dihydroergocristine can be increased when combined with Bimekizumab.The metabolism of Diltiazem can be increased when combined with Bimekizumab.The metabolism of Diphenhydramine can be increased when combined with Bimekizumab.The metabolism of Disopyramide can be increased when combined with Bimekizumab.The metabolism of Disulfiram can be increased when combined with Bimekizumab.The metabolism of Doconexent can be increased when combined with Bimekizumab.The metabolism of Dolasetron can be increased when combined with Bimekizumab.The metabolism of Donepezil can be increased when combined with Bimekizumab.The metabolism of Doravirine can be increased when combined with Bimekizumab.The metabolism of Doxazosin can be increased when combined with Bimekizumab.The metabolism of Doxepin can be increased when combined with Bimekizumab.The metabolism of Dronabinol can be increased when combined with Bimekizumab.The metabolism of Drospirenone can be increased when combined with Bimekizumab.The metabolism of Duloxetine can be increased when combined with Bimekizumab.The metabolism of Dutasteride can be increased when combined with Bimekizumab.The metabolism of Duvelisib can be increased when combined with Bimekizumab.The metabolism of Efavirenz can be increased when combined with Bimekizumab.The metabolism of Elagolix can be increased when combined with Bimekizumab.The metabolism of Elbasvir can be increased when combined with Bimekizumab.The metabolism of Eletriptan can be increased when combined with Bimekizumab.The metabolism of Elexacaftor can be increased when combined with Bimekizumab.The metabolism of Eliglustat can be increased when combined with Bimekizumab.The metabolism of Eltrombopag can be increased when combined with Bimekizumab.The metabolism of Encorafenib can be increased when combined with Bimekizumab.The metabolism of Entecavir can be increased when combined with Bimekizumab.The metabolism of Enzalutamide can be increased when combined with Bimekizumab.The metabolism of Epinastine can be increased when combined with Bimekizumab.The metabolism of Eplerenone can be increased when combined with Bimekizumab.The metabolism of Erythromycin can be increased when combined with Bimekizumab.The metabolism of Escitalopram can be increased when combined with Bimekizumab.The metabolism of Esketamine can be increased when combined with Bimekizumab.The metabolism of Esmolol can be increased when combined with Bimekizumab.The metabolism of Esomeprazole can be increased when combined with Bimekizumab.The metabolism of Estetrol can be increased when combined with Bimekizumab.The metabolism of Estradiol can be increased when combined with Bimekizumab.The metabolism of Estradiol acetate can be increased when combined with Bimekizumab.The metabolism of Estradiol cypionate can be increased when combined with Bimekizumab.The metabolism of Estradiol valerate can be increased when combined with Bimekizumab.The metabolism of Estrone sulfate can be increased when combined with Bimekizumab.The metabolism of Eszopiclone can be increased when combined with Bimekizumab.The metabolism of Ethanol can be increased when combined with Bimekizumab.The metabolism of Ethinylestradiol can be increased when combined with Bimekizumab.The metabolism of Ethosuximide can be increased when combined with Bimekizumab.The metabolism of Etodolac can be increased when combined with Bimekizumab.The risk or severity of immunosuppression can be increased when Bimekizumab is combined with Etrasimod.The metabolism of Etravirine can be increased when combined with Bimekizumab.The metabolism of Fedratinib can be increased when combined with Bimekizumab.The metabolism of Felbamate can be increased when combined with Bimekizumab.The metabolism of Felodipine can be increased when combined with Bimekizumab.The metabolism of Fenfluramine can be increased when combined with Bimekizumab.The metabolism of Fenofibrate can be increased when combined with Bimekizumab.The metabolism of Fentanyl can be increased when combined with Bimekizumab.The metabolism of Fesoterodine can be increased when combined with Bimekizumab.The metabolism of Fexinidazole can be increased when combined with Bimekizumab.The metabolism of Fezolinetant can be increased when combined with Bimekizumab.The metabolism of Finasteride can be increased when combined with Bimekizumab.The metabolism of Finerenone can be increased when combined with Bimekizumab.Bimekizumab may increase the immunosuppressive activities of Fingolimod.The metabolism of Fluoxetine can be increased when combined with Bimekizumab.The metabolism of Flurazepam can be increased when combined with Bimekizumab.The metabolism of Flurbiprofen can be increased when combined with Bimekizumab.The metabolism of Flutamide can be increased when combined with Bimekizumab.The metabolism of Fluticasone furoate can be increased when combined with Bimekizumab.The metabolism of Fluticasone propionate can be increased when combined with Bimekizumab.The metabolism of Fluvastatin can be increased when combined with Bimekizumab.The metabolism of Fluvoxamine can be increased when combined with Bimekizumab.The metabolism of Formoterol can be increased when combined with Bimekizumab.The metabolism of Fosaprepitant can be increased when combined with Bimekizumab.The metabolism of Frovatriptan can be increased when combined with Bimekizumab.The metabolism of Fruquintinib can be increased when combined with Bimekizumab.The metabolism of Fusidic acid can be increased when combined with Bimekizumab.The metabolism of Galantamine can be increased when combined with Bimekizumab.The metabolism of Gefitinib can be increased when combined with Bimekizumab.The metabolism of Genistein can be increased when combined with Bimekizumab.The metabolism of Gilteritinib can be increased when combined with Bimekizumab.The metabolism of Glasdegib can be increased when combined with Bimekizumab.The metabolism of Glimepiride can be increased when combined with Bimekizumab.The metabolism of Glipizide can be increased when combined with Bimekizumab.The metabolism of Glyburide can be increased when combined with Bimekizumab.The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Bimekizumab.The metabolism of Haloperidol can be increased when combined with Bimekizumab.The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Bimekizumab.The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Bimekizumab.The metabolism of Hydrocodone can be increased when combined with Bimekizumab.The metabolism of Hydrocortisone can be increased when combined with Bimekizumab.The metabolism of Hydrocortisone acetate can be increased when combined with Bimekizumab.The metabolism of Hydrocortisone butyrate can be increased when combined with Bimekizumab.The metabolism of Hydromorphone can be increased when combined with Bimekizumab.The metabolism of Hydroxychloroquine can be increased when combined with Bimekizumab.The metabolism of Hydroxyprogesterone caproate can be increased when combined with Bimekizumab.The metabolism of Hydroxyzine can be increased when combined with Bimekizumab.The metabolism of Ibrutinib can be increased when combined with Bimekizumab.The metabolism of Ibuprofen can be increased when combined with Bimekizumab.The metabolism of Idarubicin can be increased when combined with Bimekizumab.The metabolism of Iloperidone can be increased when combined with Bimekizumab.The metabolism of Imatinib can be increased when combined with Bimekizumab.The metabolism of Indinavir can be increased when combined with Bimekizumab.The metabolism of Indomethacin can be increased when combined with Bimekizumab.The metabolism of Infigratinib can be increased when combined with Bimekizumab.The metabolism of Ipecac can be increased when combined with Bimekizumab.The metabolism of Iptacopan can be increased when combined with Bimekizumab.The metabolism of Irbesartan can be increased when combined with Bimekizumab.The metabolism of Isavuconazonium can be increased when combined with Bimekizumab.The metabolism of Isoflurane can be increased when combined with Bimekizumab.The metabolism of Istradefylline can be increased when combined with Bimekizumab.The metabolism of Ivacaftor can be increased when combined with Bimekizumab.The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bimekizumab.The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Bimekizumab.The metabolism of Ketamine can be increased when combined with Bimekizumab.The metabolism of Ketorolac can be increased when combined with Bimekizumab.The metabolism of Labetalol can be increased when combined with Bimekizumab.The metabolism of Lacosamide can be increased when combined with Bimekizumab.The metabolism of Lansoprazole can be increased when combined with Bimekizumab.The metabolism of Lapatinib can be increased when combined with Bimekizumab.The metabolism of Lefamulin can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Leflunomide.The metabolism of Lemborexant can be increased when combined with Bimekizumab.The metabolism of Letrozole can be increased when combined with Bimekizumab.The metabolism of Levamlodipine can be increased when combined with Bimekizumab.The metabolism of Levonorgestrel can be increased when combined with Bimekizumab.The metabolism of Lidocaine can be increased when combined with Bimekizumab.The metabolism of Linagliptin can be increased when combined with Bimekizumab.The metabolism of Lofexidine can be increased when combined with Bimekizumab.The metabolism of Lomefloxacin can be increased when combined with Bimekizumab.The metabolism of Lonafarnib can be increased when combined with Bimekizumab.The metabolism of Loperamide can be increased when combined with Bimekizumab.The serum concentration of Bimekizumab can be increased when it is combined with Lopinavir.The metabolism of Lorlatinib can be increased when combined with Bimekizumab.The metabolism of Losartan can be increased when combined with Bimekizumab.The metabolism of Lovastatin can be increased when combined with Bimekizumab.The serum concentration of Magnesium can be decreased when it is combined with Bimekizumab.The metabolism of Maprotiline can be increased when combined with Bimekizumab.The metabolism of Mavacamten can be increased when combined with Bimekizumab.The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Bimekizumab.The metabolism of Meclizine can be increased when combined with Bimekizumab.The metabolism of Mefenamic acid can be increased when combined with Bimekizumab.The metabolism of Melatonin can be increased when combined with Bimekizumab.The metabolism of Meloxicam can be increased when combined with Bimekizumab.The metabolism of Meperidine can be increased when combined with Bimekizumab.The metabolism of Metamfetamine can be increased when combined with Bimekizumab.The metabolism of Methadone can be increased when combined with Bimekizumab.The metabolism of Methsuximide can be increased when combined with Bimekizumab.The metabolism of Methylene blue can be increased when combined with Bimekizumab.The metabolism of Methyltestosterone can be increased when combined with Bimekizumab.The metabolism of Metoclopramide can be increased when combined with Bimekizumab.The metabolism of Metoprolol can be increased when combined with Bimekizumab.The metabolism of Metronidazole can be increased when combined with Bimekizumab.The metabolism of Mexiletine can be increased when combined with Bimekizumab.The metabolism of Midazolam can be increased when combined with Bimekizumab.The metabolism of Mifepristone can be increased when combined with Bimekizumab.The metabolism of Mirabegron can be increased when combined with Bimekizumab.The metabolism of Mirtazapine can be increased when combined with Bimekizumab.The metabolism of Modafinil can be increased when combined with Bimekizumab.The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Bimekizumab.The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Bimekizumab.The metabolism of Montelukast can be increased when combined with Bimekizumab.The metabolism of Morphine can be increased when combined with Bimekizumab.The therapeutic efficacy of Mumps virus strain B level jeryl lynn live antigen can be decreased when used in combination with Bimekizumab.The metabolism of Mycophenolate mofetil can be increased when combined with Bimekizumab.The metabolism of Nabilone can be increased when combined with Bimekizumab.The metabolism of Nabumetone can be increased when combined with Bimekizumab.The metabolism of Nadolol can be increased when combined with Bimekizumab.The metabolism of Naproxen can be increased when combined with Bimekizumab.The metabolism of Nateglinide can be increased when combined with Bimekizumab.The metabolism of Nebivolol can be increased when combined with Bimekizumab.The metabolism of Nefazodone can be increased when combined with Bimekizumab.The metabolism of Nelfinavir can be increased when combined with Bimekizumab.The metabolism of Netupitant can be increased when combined with Bimekizumab.The metabolism of Nevirapine can be increased when combined with Bimekizumab.The metabolism of Nicardipine can be increased when combined with Bimekizumab.The metabolism of Nicotine can be increased when combined with Bimekizumab.The metabolism of Nifedipine can be increased when combined with Bimekizumab.The metabolism of Nilutamide can be increased when combined with Bimekizumab.The metabolism of Nintedanib can be increased when combined with Bimekizumab.The metabolism of Nirogacestat can be increased when combined with Bimekizumab.The metabolism of Nisoldipine can be increased when combined with Bimekizumab.The metabolism of Norethisterone can be increased when combined with Bimekizumab.The metabolism of Norgestimate can be increased when combined with Bimekizumab.The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Bimekizumab.The metabolism of Olanzapine can be increased when combined with Bimekizumab.The metabolism of Oliceridine can be increased when combined with Bimekizumab.The metabolism of Olodaterol can be increased when combined with Bimekizumab.The metabolism of Ombitasvir can be increased when combined with Bimekizumab.The metabolism of Omeprazole can be increased when combined with Bimekizumab.The metabolism of Ondansetron can be increased when combined with Bimekizumab.The metabolism of Opium can be increased when combined with Bimekizumab.The metabolism of Osilodrostat can be increased when combined with Bimekizumab.The metabolism of Ospemifene can be increased when combined with Bimekizumab.The metabolism of Oxybutynin can be increased when combined with Bimekizumab.The metabolism of Oxycodone can be increased when combined with Bimekizumab.The metabolism of Oxymorphone can be increased when combined with Bimekizumab.The metabolism of Paliperidone can be increased when combined with Bimekizumab.The metabolism of Palonosetron can be increased when combined with Bimekizumab.The metabolism of Pantoprazole can be increased when combined with Bimekizumab.The metabolism of Parecoxib can be increased when combined with Bimekizumab.The metabolism of Paritaprevir can be increased when combined with Bimekizumab.The metabolism of Paroxetine can be increased when combined with Bimekizumab.The metabolism of Pemetrexed can be increased when combined with Bimekizumab.The metabolism of Penciclovir can be increased when combined with Bimekizumab.The metabolism of Pentamidine can be increased when combined with Bimekizumab.The metabolism of Pentobarbital can be increased when combined with Bimekizumab.The metabolism of Pentoxifylline can be increased when combined with Bimekizumab.The metabolism of Perampanel can be increased when combined with Bimekizumab.The metabolism of Perphenazine can be increased when combined with Bimekizumab.The metabolism of Pimavanserin can be increased when combined with Bimekizumab.The metabolism of Pindolol can be increased when combined with Bimekizumab.The metabolism of Pioglitazone can be increased when combined with Bimekizumab.The metabolism of Pirfenidone can be increased when combined with Bimekizumab.The metabolism of Piroxicam can be increased when combined with Bimekizumab.The metabolism of Pitolisant can be increased when combined with Bimekizumab.The metabolism of Ponesimod can be increased when combined with Bimekizumab.The serum concentration of Pozelimab can be decreased when it is combined with Bimekizumab.The metabolism of Prasterone can be increased when combined with Bimekizumab.The metabolism of Prasugrel can be increased when combined with Bimekizumab.The metabolism of Praziquantel can be increased when combined with Bimekizumab.The metabolism of Pretomanid can be increased when combined with Bimekizumab.The metabolism of Primaquine can be increased when combined with Bimekizumab.The metabolism of Primidone can be increased when combined with Bimekizumab.The metabolism of Prochlorperazine can be increased when combined with Bimekizumab.The metabolism of Progesterone can be increased when combined with Bimekizumab.The metabolism of Proguanil can be increased when combined with Bimekizumab.The metabolism of Promethazine can be increased when combined with Bimekizumab.The metabolism of Propafenone can be increased when combined with Bimekizumab.The metabolism of Propofol can be increased when combined with Bimekizumab.The metabolism of Propranolol can be increased when combined with Bimekizumab.The metabolism of Quetiapine can be increased when combined with Bimekizumab.The metabolism of Quinine can be increased when combined with Bimekizumab.The metabolism of Quizartinib can be increased when combined with Bimekizumab.The metabolism of Rabeprazole can be increased when combined with Bimekizumab.The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Bimekizumab.The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Bimekizumab.The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Bimekizumab.The metabolism of Ramelteon can be increased when combined with Bimekizumab.The metabolism of Ranitidine can be increased when combined with Bimekizumab.The metabolism of Ranolazine can be increased when combined with Bimekizumab.The metabolism of Rasagiline can be increased when combined with Bimekizumab.The metabolism of Relugolix can be increased when combined with Bimekizumab.The metabolism of Repaglinide can be increased when combined with Bimekizumab.The metabolism of Resmetirom can be increased when combined with Bimekizumab.The therapeutic efficacy of GSK-3844766A can be decreased when used in combination with Bimekizumab.The metabolism of Revefenacin can be increased when combined with Bimekizumab.The metabolism of Rilpivirine can be increased when combined with Bimekizumab.The metabolism of Riluzole can be increased when combined with Bimekizumab.The metabolism of Riociguat can be increased when combined with Bimekizumab.The metabolism of Risperidone can be increased when combined with Bimekizumab.The metabolism of Ritonavir can be increased when combined with Bimekizumab.The metabolism of Rivaroxaban can be increased when combined with Bimekizumab.The metabolism of Ropinirole can be increased when combined with Bimekizumab.The metabolism of Ropivacaine can be increased when combined with Bimekizumab.The metabolism of Rosiglitazone can be increased when combined with Bimekizumab.The metabolism of Rosuvastatin can be increased when combined with Bimekizumab.The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Bimekizumab.The metabolism of Rotigotine can be increased when combined with Bimekizumab.The metabolism of Rucaparib can be increased when combined with Bimekizumab.The metabolism of Salicylic acid can be increased when combined with Bimekizumab.The metabolism of Salmeterol can be increased when combined with Bimekizumab.The metabolism of Saquinavir can be increased when combined with Bimekizumab.The metabolism of Saxagliptin can be increased when combined with Bimekizumab.The metabolism of Seladelpar can be increased when combined with Bimekizumab.The metabolism of Selegiline can be increased when combined with Bimekizumab.The metabolism of Selexipag can be increased when combined with Bimekizumab.The metabolism of Selumetinib can be increased when combined with Bimekizumab.The metabolism of Sertraline can be increased when combined with Bimekizumab.The metabolism of Sevoflurane can be increased when combined with Bimekizumab.The metabolism of Sildenafil can be increased when combined with Bimekizumab.The metabolism of Simvastatin can be increased when combined with Bimekizumab.The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Bimekizumab.The metabolism of Sitagliptin can be increased when combined with Bimekizumab.The metabolism of Solifenacin can be increased when combined with Bimekizumab.The metabolism of Stiripentol can be increased when combined with Bimekizumab.The metabolism of Sulfadiazine can be increased when combined with Bimekizumab.The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Bimekizumab.The metabolism of Suvorexant can be increased when combined with Bimekizumab.Tacrolimus may increase the immunosuppressive activities of Bimekizumab.The metabolism of Tafenoquine can be increased when combined with Bimekizumab.The metabolism of Tamsulosin can be increased when combined with Bimekizumab.The metabolism of Tasimelteon can be increased when combined with Bimekizumab.The metabolism of Tazarotene can be increased when combined with Bimekizumab.The metabolism of Tazemetostat can be increased when combined with Bimekizumab.The metabolism of Tegaserod can be increased when combined with Bimekizumab.The metabolism of Telithromycin can be increased when combined with Bimekizumab.The metabolism of Tenofovir alafenamide can be increased when combined with Bimekizumab.The metabolism of Terbinafine can be increased when combined with Bimekizumab.The metabolism of Testosterone can be increased when combined with Bimekizumab.The metabolism of Testosterone cypionate can be increased when combined with Bimekizumab.The metabolism of Testosterone enanthate can be increased when combined with Bimekizumab.The metabolism of Tetrabenazine can be increased when combined with Bimekizumab.The metabolism of Tezacaftor can be increased when combined with Bimekizumab.The metabolism of Thalidomide can be increased when combined with Bimekizumab.The metabolism of Thioridazine can be increased when combined with Bimekizumab.The metabolism of Thiothixene can be increased when combined with Bimekizumab.The metabolism of Ticagrelor can be increased when combined with Bimekizumab.The therapeutic efficacy of Tick-borne encephalitis vaccine (whole virus, inactivated) can be decreased when used in combination with Bimekizumab.The metabolism of Ticlopidine can be increased when combined with Bimekizumab.The metabolism of Timolol can be increased when combined with Bimekizumab.The metabolism of Tiotropium can be increased when combined with Bimekizumab.The metabolism of Tipranavir can be increased when combined with Bimekizumab.Bimekizumab may increase the immunosuppressive activities of Tofacitinib.The metabolism of Tolazamide can be increased when combined with Bimekizumab.The metabolism of Tolterodine can be increased when combined with Bimekizumab.The metabolism of Torasemide can be increased when combined with Bimekizumab.The metabolism of Tovorafenib can be increased when combined with Bimekizumab.The metabolism of Tramadol can be increased when combined with Bimekizumab.The risk or severity of neutropenia can be increased when Trastuzumab is combined with Bimekizumab.The metabolism of Trazodone can be increased when combined with Bimekizumab.The metabolism of Treprostinil can be increased when combined with Bimekizumab.The metabolism of Tretinoin can be increased when combined with Bimekizumab.The metabolism of Triamcinolone can be increased when combined with Bimekizumab.The metabolism of Triamterene can be increased when combined with Bimekizumab.The metabolism of Triazolam can be increased when combined with Bimekizumab.The metabolism of Triclabendazole can be increased when combined with Bimekizumab.The metabolism of Trifluoperazine can be increased when combined with Bimekizumab.The metabolism of Trimethoprim can be increased when combined with Bimekizumab.The metabolism of Tucatinib can be increased when combined with Bimekizumab.The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Bimekizumab.The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Bimekizumab.The risk or severity of infection can be increased when Ublituximab is combined with Bimekizumab.The metabolism of Umeclidinium can be increased when combined with Bimekizumab.The metabolism of Valbenazine can be increased when combined with Bimekizumab.The metabolism of Valdecoxib can be increased when combined with Bimekizumab.The metabolism of Valproic acid can be increased when combined with Bimekizumab.The metabolism of Valsartan can be increased when combined with Bimekizumab.The metabolism of Vardenafil can be increased when combined with Bimekizumab.The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Bimekizumab.The metabolism of Velpatasvir can be increased when combined with Bimekizumab.The metabolism of Venlafaxine can be increased when combined with Bimekizumab.The metabolism of Verapamil can be increased when combined with Bimekizumab.The metabolism of Vilazodone can be increased when combined with Bimekizumab.The metabolism of Vonoprazan can be increased when combined with Bimekizumab.The metabolism of Vorapaxar can be increased when combined with Bimekizumab.The metabolism of Vorasidenib can be increased when combined with Bimekizumab.The metabolism of Voriconazole can be increased when combined with Bimekizumab.The metabolism of Vortioxetine can be increased when combined with Bimekizumab.The metabolism of Voxelotor can be increased when combined with Bimekizumab.The metabolism of Voxilaprevir can be increased when combined with Bimekizumab.The metabolism of Xanomeline can be increased when combined with Bimekizumab.The metabolism of Zafirlukast can be increased when combined with Bimekizumab.The metabolism of Zaleplon can be increased when combined with Bimekizumab.The metabolism of Zidovudine can be increased when combined with Bimekizumab.The metabolism of Zileuton can be increased when combined with Bimekizumab.The metabolism of Ziprasidone can be increased when combined with Bimekizumab.The metabolism of Zolmitriptan can be increased when combined with Bimekizumab.The metabolism of Zolpidem can be increased when combined with Bimekizumab.The metabolism of Zonisamide can be increased when combined with Bimekizumab.The risk or severity of adverse effects can be increased when Aducanumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Alirocumab is combined with Bimekizumab.The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Amivantamab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Ansuvimab.The risk or severity of adverse effects can be increased when Asfotase alfa is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Atezolizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Atoltivimab.The risk or severity of adverse effects can be increased when Avelumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Axatilimab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Bamlanivimab.The risk or severity of adverse effects can be increased when Benralizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bevacizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Bezlotoxumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Brolucizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Burosumab.The risk or severity of adverse effects can be increased when Caplacizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Cemiplimab.The risk or severity of adverse effects can be increased when Cetuximab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Cilgavimab.Bimekizumab may increase the immunosuppressive activities of Cladribine.The risk or severity of adverse effects can be increased when Daratumumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Donanemab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Dostarlimab.The risk or severity of adverse effects can be increased when Dulaglutide is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Dupilumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Durvalumab is combined with Bimekizumab.The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Eflapegrastim.The risk or severity of adverse effects can be increased when Eftrenonacog alfa is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Elotuzumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Emicizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Eptinezumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Erenumab.Esterified estrogens may increase the thrombogenic activities of Bimekizumab.Estriol may increase the thrombogenic activities of Bimekizumab.The risk or severity of adverse effects can be increased when Evolocumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Fanolesomab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Fremanezumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Galcanezumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Glofitamab.The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Human cytomegalovirus immune globulin.The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Human Rho(D) immune globulin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Human varicella-zoster immune globulin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ibalizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Idarucizumab is combined with Bimekizumab.The risk or severity of infection can be increased when Bimekizumab is combined with Inebilizumab.The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ipilimumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Isatuximab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Lanadelumab.The risk or severity of adverse effects can be increased when Lebrikizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Lecanemab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Loncastuximab tesirine.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Maftivimab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Margetuximab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Marstacimab.The risk or severity of adverse effects can be increased when Mirvetuximab Soravtansine is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Mogamulizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Necitumumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Nemolizumab.The serum concentration of Bimekizumab can be decreased when it is combined with Nipocalimab.The risk or severity of adverse effects can be increased when Nivolumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Odesivimab.The risk or severity of adverse effects can be increased when Olaratumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Palivizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Panitumumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Pembrolizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Penpulimab.The risk or severity of adverse effects can be increased when Pertuzumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ramucirumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ranibizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Raxibacumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Relatlimab.The risk or severity of adverse effects can be increased when Reslizumab is combined with Bimekizumab.Roflumilast may increase the immunosuppressive activities of Bimekizumab.The risk or severity of adverse effects can be increased when Romosozumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Sacituzumab govitecan is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Sotatercept is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Sotrovimab.Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Bimekizumab.Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Tafasitamab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Telisotuzumab vedotin.The risk or severity of adverse effects can be increased when Teplizumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Tetanus immune globulin, human is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Tezepelumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Tildrakizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Tislelizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Tisotumab vedotin.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Tixagevimab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Toripalimab.The risk or severity of adverse effects can be increased when Tralokinumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Trastuzumab deruxtecan.The risk or severity of adverse effects can be increased when Tremelimumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Ustekinumab is combined with Bimekizumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Vilobelimab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Zanidatamab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Zenocutuzumab.The risk or severity of adverse effects can be increased when Bimekizumab is combined with Zolbetuximab.
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Bimzelx®.
Abatacept
Abemaciclib
Acalabrutinib
Acenocoumarol
Adalimumab
Adenovirus type 7 vaccine live
Aldesleukin
Alectinib
Alemtuzumab
Alpelisib
Aminophylline
Amiodarone
Amitriptyline
Amoxapine
Anagrelide
Anakinra
Anifrolumab
Anthrax vaccine
Antilymphocyte immunoglobulin (horse)
Antithymocyte immunoglobulin (rabbit)
Arsenic trioxide
Avacopan
Axitinib
Azacitidine
Bacillus calmette-guerin substrain tice live antigen
Baricitinib
Basiliximab
Beclomethasone dipropionate
Belatacept
Belimumab
Belinostat
Belumosudil
Bendamustine
Betamethasone
Bicalutamide
Binimetinib
Bleomycin
Blinatumomab
Bortezomib
Bosutinib
Brentuximab vedotin
Brigatinib
Brodalumab
Budesonide
Busulfan
Cabazitaxel
Cabergoline
Cabozantinib
Canakinumab
Capecitabine
Carbamazepine
Carboplatin
Carfilzomib
Ceritinib
Certolizumab pegol
Chikungunya vaccine (live, attenuated)
Chlorambucil
Chloramphenicol
Cisplatin
Clobetasol propionate
Clofarabine
Clomipramine
Clonidine
Cobimetinib
Conivaptan
Copanlisib
Corticotropin
Cortisone acetate
Crizotinib
Crovalimab
Cyclophosphamide
Cyclosporine
Cytarabine
Dabrafenib
Dacarbazine
Dacomitinib
Dactinomycin
Danicopan
Dasatinib
Daunorubicin
Decitabine
Deflazacort
Desipramine
Desoximetasone
Deucravacitinib
Dexrazoxane
Dihydroergotamine
Dimethyl fumarate
Dinutuximab
Diroximel fumarate
Docetaxel
Dofetilide
Doxorubicin
Dronedarone
Eculizumab
Efgartigimod alfa
Emapalumab
Enasidenib
Entrectinib
Epirubicin
Erdafitinib
Ergotamine
Eribulin
Erlotinib
Etanercept
Etoposide
Everolimus
Flecainide
Floxuridine
Flucytosine
Fludarabine
Fludrocortisone
Flunisolide
Fluocinolone acetonide
Fluocinonide
Fluorometholone
Fluorouracil
Fosphenytoin
Gemcitabine
Gemtuzumab ozogamicin
Glatiramer
Golimumab
Guselkumab
Human adenovirus e serotype 4 strain cl-68578 antigen
Hydrocortisone succinate
Hydroxyurea
Ibritumomab tiuxetan
Idelalisib
Ifosfamide
Imipramine
Infliximab
Interferon alfa-2b
Interferon alfa-n3
Interferon beta-1b
Interferon gamma-1b
Irinotecan
Ivosidenib
Ixabepilone
Ixazomib
Ixekizumab
Lenalidomide
Linezolid
Lomitapide
Lomustine
Mechlorethamine
Melphalan
Mepolizumab
Mercaptopurine
Methimazole
Methotrexate
Methylprednisolone
Midostaurin
Mirikizumab
Mitomycin
Mitoxantrone
Mometasone furoate
Monomethyl fumarate
Mosunetuzumab
Mycophenolic acid
Natalizumab
Nelarabine
Neratinib
Nilotinib
Nortriptyline
Obinutuzumab
Ocrelizumab
Ofatumumab
Olaparib
Osimertinib
Oxaliplatin
Ozanimod
Paclitaxel
Palbociclib
Panobinostat
Pazopanib
Pegaspargase
Pegcetacoplan
Peginterferon alfa-2a
Peginterferon alfa-2b
Peginterferon beta-1a
Penicillamine
Pentostatin
Pexidartinib
Phenobarbital
Phenylalanine
Phenytoin
Pimecrolimus
Pimozide
Pirtobrutinib
Pomalidomide
Ponatinib
Pralatrexate
Prednisolone
Prednisone
Procainamide
Procarbazine
Propylthiouracil
Quinidine
Ravulizumab
Regorafenib
Ribociclib
Rilonacept
Risankizumab
Ritlecitinib
Rituximab
Romidepsin
Ropeginterferon alfa-2b
Rozanolixizumab
Rubella virus vaccine
Ruxolitinib
Sarilumab
Satralizumab
Secukinumab
Siltuximab
Siponimod
Sirolimus
Smallpox (Vaccinia) Vaccine, Live
Sonidegib
Sorafenib
Sotalol
Spesolimab
Streptozocin
Sulfasalazine
Sunitinib
Sutimlimab
Tamoxifen
Temozolomide
Temsirolimus
Teniposide
Teprotumumab
Teriflunomide
Theophylline
Thiotepa
Tioguanine
Tixocortol
Tizanidine
Tocilizumab
Tolvaptan
Topotecan
Trabectedin
Trastuzumab emtansine
Trifluridine
Trimipramine
Typhoid Vaccine Live
Upadacitinib
Vandetanib
Varicella zoster vaccine (live/attenuated)
Vedolizumab
Vemurafenib
Venetoclax
Vibrio cholerae CVD 103-HgR strain live antigen
Vilanterol
Vinblastine
Vincristine
Vinorelbine
Voclosporin
Vorinostat
Warfarin
Yellow fever vaccine
Zanubrutinib
Zilucoplan
Abrocitinib
Acebutolol
Acetaminophen
Acetylsalicylic acid
Acyclovir
Albendazole
Alfentanil
Almotriptan
Alogliptin
Alosetron
Alprazolam
Ambrisentan
Amphetamine
Anastrozole
Anthrax immune globulin human
Antipyrine
Apalutamide
Apixaban
Apomorphine
Apremilast
Aprepitant
Arformoterol
Aripiprazole
Aripiprazole lauroxil
Artemether
Asenapine
AstraZeneca COVID-19 Vaccine
Asunaprevir
Atazanavir
Atenolol
Atomoxetine
Atorvastatin
Avanafil
Avapritinib
Avatrombopag
Azathioprine
Azelastine
Azithromycin
Belzutifan
Benzatropine
Benzocaine
Benzphetamine
Benzyl alcohol
Betaxolol
Bexarotene
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
Bosentan
Brexpiprazole
Brivaracetam
Bromotheophylline
Brompheniramine
Bupivacaine
Buprenorphine
Bupropion
Buspirone
Caffeine
Candesartan cilexetil
Cannabidiol
Capsaicin
Carisoprodol
Carmustine
Carvedilol
Celecoxib
Cenobamate
Cephalexin
Cevimeline
Chloroquine
Chlorpheniramine
Chlorpromazine
Chlorzoxazone
Ciclesonide
Cilostazol
Cinacalcet
Citalopram
Clarithromycin
Clevidipine
Clindamycin
Clobazam
Clopidogrel
Clostridium tetani toxoid antigen (formaldehyde inactivated)
Clozapine
Cobicistat
Codeine
Conjugated estrogens
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
Cyclobenzaprine
Daprodustat
Dapsone
Darifenacin
Dasabuvir
Denosumab
Desogestrel
Desvenlafaxine
Deuruxolitinib
Deutetrabenazine
Dexamethasone
Dexamethasone acetate
Dexchlorpheniramine maleate
Dexlansoprazole
Dextroamphetamine
Dextromethorphan
Dextropropoxyphene
Diazepam
Diazoxide
Diclofenac
Dihydrocodeine
Dihydroergocornine
Dihydroergocristine
Diltiazem
Diphenhydramine
Disopyramide
Disulfiram
Doconexent
Dolasetron
Donepezil
Doravirine
Doxazosin
Doxepin
Dronabinol
Drospirenone
Duloxetine
Dutasteride
Duvelisib
Efavirenz
Elagolix
Elbasvir
Eletriptan
Elexacaftor
Eliglustat
Eltrombopag
Encorafenib
Entecavir
Enzalutamide
Epinastine
Eplerenone
Erythromycin
Escitalopram
Esketamine
Esmolol
Esomeprazole
Estetrol
Estradiol
Estradiol acetate
Estradiol cypionate
Estradiol valerate
Estrone sulfate
Eszopiclone
Ethanol
Ethinylestradiol
Ethosuximide
Etodolac
Etrasimod
Etravirine
Fedratinib
Felbamate
Felodipine
Fenfluramine
Fenofibrate
Fentanyl
Fesoterodine
Fexinidazole
Fezolinetant
Finasteride
Finerenone
Fingolimod
Fluoxetine
Flurazepam
Flurbiprofen
Flutamide
Fluticasone furoate
Fluticasone propionate
Fluvastatin
Fluvoxamine
Formoterol
Fosaprepitant
Frovatriptan
Fruquintinib
Fusidic acid
Galantamine
Gefitinib
Genistein
Gilteritinib
Glasdegib
Glimepiride
Glipizide
Glyburide
Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
Haloperidol
Hepatitis A Vaccine
Hepatitis B Vaccine (Recombinant)
Hydrocodone
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone butyrate
Hydromorphone
Hydroxychloroquine
Hydroxyprogesterone caproate
Hydroxyzine
Ibrutinib
Ibuprofen
Idarubicin
Iloperidone
Imatinib
Indinavir
Indomethacin
Infigratinib
Ipecac
Iptacopan
Irbesartan
Isavuconazonium
Isoflurane
Istradefylline
Ivacaftor
Janssen COVID-19 Vaccine
Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
Ketamine
Ketorolac
Labetalol
Lacosamide
Lansoprazole
Lapatinib
Lefamulin
Leflunomide
Lemborexant
Letrozole
Levamlodipine
Levonorgestrel
Lidocaine
Linagliptin
Lofexidine
Lomefloxacin
Lonafarnib
Loperamide
Lopinavir
Lorlatinib
Losartan
Lovastatin
Magnesium
Maprotiline
Mavacamten
Measles virus vaccine live attenuated
Meclizine
Mefenamic acid
Melatonin
Meloxicam
Meperidine
Metamfetamine
Methadone
Methsuximide
Methylene blue
Methyltestosterone
Metoclopramide
Metoprolol
Metronidazole
Mexiletine
Midazolam
Mifepristone
Mirabegron
Mirtazapine
Modafinil
Moderna COVID-19 Vaccine
Modified vaccinia ankara
Montelukast
Morphine
Mumps virus strain B level jeryl lynn live antigen
Mycophenolate mofetil
Nabilone
Nabumetone
Nadolol
Naproxen
Nateglinide
Nebivolol
Nefazodone
Nelfinavir
Netupitant
Nevirapine
Nicardipine
Nicotine
Nifedipine
Nilutamide
Nintedanib
Nirogacestat
Nisoldipine
Norethisterone
Norgestimate
Nuvaxovid
Olanzapine
Oliceridine
Olodaterol
Ombitasvir
Omeprazole
Ondansetron
Opium
Osilodrostat
Ospemifene
Oxybutynin
Oxycodone
Oxymorphone
Paliperidone
Palonosetron
Pantoprazole
Parecoxib
Paritaprevir
Paroxetine
Pemetrexed
Penciclovir
Pentamidine
Pentobarbital
Pentoxifylline
Perampanel
Perphenazine
Pimavanserin
Pindolol
Pioglitazone
Pirfenidone
Piroxicam
Pitolisant
Ponesimod
Pozelimab
Prasterone
Prasugrel
Praziquantel
Pretomanid
Primaquine
Primidone
Prochlorperazine
Progesterone
Proguanil
Promethazine
Propafenone
Propofol
Propranolol
Quetiapine
Quinine
Quizartinib
Rabeprazole
Rabies immune globulin, human
Rabies virus inactivated antigen, A
Rabies virus inactivated antigen, B
Ramelteon
Ranitidine
Ranolazine
Rasagiline
Relugolix
Repaglinide
Resmetirom
Respiratory syncytial virus vaccine, adjuvanted
Revefenacin
Rilpivirine
Riluzole
Riociguat
Risperidone
Ritonavir
Rivaroxaban
Ropinirole
Ropivacaine
Rosiglitazone
Rosuvastatin
Rotavirus vaccine
Rotigotine
Rucaparib
Salicylic acid
Salmeterol
Saquinavir
Saxagliptin
Seladelpar
Selegiline
Selexipag
Selumetinib
Sertraline
Sevoflurane
Sildenafil
Simvastatin
Sipuleucel-T
Sitagliptin
Solifenacin
Stiripentol
Sulfadiazine
Sulfamethoxazole
Suvorexant
Tacrolimus
Tafenoquine
Tamsulosin
Tasimelteon
Tazarotene
Tazemetostat
Tegaserod
Telithromycin
Tenofovir alafenamide
Terbinafine
Testosterone
Testosterone cypionate
Testosterone enanthate
Tetrabenazine
Tezacaftor
Thalidomide
Thioridazine
Thiothixene
Ticagrelor
Tick-borne encephalitis vaccine (whole virus, inactivated)
Ticlopidine
Timolol
Tiotropium
Tipranavir
Tofacitinib
Tolazamide
Tolterodine
Torasemide
Tovorafenib
Tramadol
Trastuzumab
Trazodone
Treprostinil
Tretinoin
Triamcinolone
Triamterene
Triazolam
Triclabendazole
Trifluoperazine
Trimethoprim
Tucatinib
Typhoid vaccine
Typhoid Vi polysaccharide vaccine
Ublituximab
Umeclidinium
Valbenazine
Valdecoxib
Valproic acid
Valsartan
Vardenafil
Varicella zoster vaccine (recombinant)
Velpatasvir
Venlafaxine
Verapamil
Vilazodone
Vonoprazan
Vorapaxar
Vorasidenib
Voriconazole
Vortioxetine
Voxelotor
Voxilaprevir
Xanomeline
Zafirlukast
Zaleplon
Zidovudine
Zileuton
Ziprasidone
Zolmitriptan
Zolpidem
Zonisamide
Aducanumab
Alirocumab
Allogeneic processed thymus tissue
Amivantamab
Ansuvimab
Asfotase alfa
Atezolizumab
Atoltivimab
Avelumab
Axatilimab
Bamlanivimab
Benralizumab
Bevacizumab
Bezlotoxumab
Brolucizumab
Burosumab
Caplacizumab
Cemiplimab
Cetuximab
Cilgavimab
Cladribine
Daratumumab
Digoxin Immune Fab (Ovine)
Donanemab
Dostarlimab
Dulaglutide
Dupilumab
Durvalumab
Ebola Zaire vaccine (live, attenuated)
Eflapegrastim
Eftrenonacog alfa
Elotuzumab
Emicizumab
Eptinezumab
Erenumab
Esterified estrogens
Estriol
Evolocumab
Fanolesomab
Fremanezumab
Galcanezumab
Glofitamab
Hepatitis B immune globulin
Human cytomegalovirus immune globulin
Human immunoglobulin G
Human Rho(D) immune globulin
Human varicella-zoster immune globulin
Ibalizumab
Idarucizumab
Inebilizumab
Inotuzumab ozogamicin
Ipilimumab
Isatuximab
Lanadelumab
Lebrikizumab
Lecanemab
Loncastuximab tesirine
Maftivimab
Margetuximab
Marstacimab
Mirvetuximab soravtansine
Mogamulizumab
Necitumumab
Nemolizumab
Nipocalimab
Nivolumab
Obiltoxaximab
Odesivimab
Olaratumab
Omalizumab
Palivizumab
Panitumumab
Pembrolizumab
Penpulimab
Pertuzumab
Polatuzumab vedotin
Ramucirumab
Ranibizumab
Raxibacumab
Relatlimab
Reslizumab
Roflumilast
Romosozumab
Sacituzumab govitecan
Sotatercept
Sotrovimab
Synthetic Conjugated Estrogens, A
Synthetic Conjugated Estrogens, B
Tafasitamab
Telisotuzumab vedotin
Teplizumab
Tetanus immune globulin, human
Tezepelumab
Tildrakizumab
Tislelizumab
Tisotumab vedotin
Tixagevimab
Toripalimab
Tralokinumab
Trastuzumab deruxtecan
Tremelimumab
Ustekinumab
Vilobelimab
Zanidatamab
Zenocutuzumab
Zolbetuximab